TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17055767

Group type: EXPERIMENTAL
Intervention: Best practice physiotherapy
Number of subjects: 173

Group type: COMPARATOR
Intervention: No physiotherapy (Control)
Number of subjects: 173
Study: 15119877

Group type: EXPERIMENTAL
Intervention: Fixed prosthesis (n = 11)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Overdenture (n = 6)
Number of subjects: 17
Study: 11110928

Group type: EXPERIMENTAL
Intervention: Hydrodynamic thrombectomy system
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pulse-spray thrombolysis
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Thrombus treatment time for thrombectomy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Thrombus treatment time for thrombolysis
Number of subjects: 120
Study: 8958538

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25%
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Lignocaine 1%
Number of subjects: 107

Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 107
Study: 1389191

Group type: EXPERIMENTAL
Intervention: Desflurane in 60% N2O
Number of subjects: 34

Group type: COMPARATOR
Intervention: Isoflurane in 60% N2O
Number of subjects: 34
Study: 2581324

Group type: EXPERIMENTAL
Intervention: Isoxicam 200 mg once daily
Number of subjects: 309

Group type: COMPARATOR
Intervention: Indomethacin 25 mg 3 times a day
Number of subjects: 309
Study: 30637748

Group type: EXPERIMENTAL
Intervention: Platelet rich fibrin (PRF) membrane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Collagen membrane (CM) incorporated with recombinant human PDGF‐BB (rhPDGF‐BB)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both PRF membrane and CM incorporated with rhPDGF‐BB
Number of subjects: 20
Study: 27612525

Group type: EXPERIMENTAL
Intervention: Corticosteroids (methylprednisolone 32 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined therapy (methylprednisolone 32 mg and meloxicam 15 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NSAIDs (meloxicam 15 mg)
Number of subjects: 60
Study: 25057930

Group type: EXPERIMENTAL
Intervention: Echogenic needles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional needles
Number of subjects: 0
Study: 22717018

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 21696732

Group type: EXPERIMENTAL
Intervention: Single-dose fosfomycin trometamol
Number of subjects: 90

Group type: COMPARATOR
Intervention: 5-day course of amoxicillin clavulanate
Number of subjects: 90

Group type: COMPARATOR
Intervention: 5-day course of cefuroxime axetil
Number of subjects: 90
Study: 18224344

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors for mild IgA nephropathy
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Steroids for severe IgA nephropathy
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Period 1990-2004
Number of subjects: 500

Group type: COMPARATOR
Intervention: Period 1976-1989
Number of subjects: 500
Study: 17194243

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (Cr) supplementation at a dose of 0.3 g.kg(‐1) for the initial 7 days and 0.03 g.kg(‐1) for subsequent 9 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (Pl) at a dose of 0.3 g.kg(‐1) for the initial 7 days and 0.03 g.kg(‐1) for subsequent 9 weeks
Number of subjects: 26
Study: 14989126

Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multimodality treatment including IORT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multimodality treatment without IORT
Number of subjects: 0
Study: 10505694

Group type: EXPERIMENTAL
Intervention: Cuprophan membrane (CU)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Polymethylmethacrylate membrane (PMMA)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Nondialyzed uremic patients (UR)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 38
Study: 8756734

Group type: EXPERIMENTAL
Intervention: Clostilbegyt treatment (50 mg daily for 240 days)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: HCG stimulation (6000 units of Biogonadyl through 2 days)
Number of subjects: 57
Study: 1818002

Group type: EXPERIMENTAL
Intervention: Gallopamil (50 mcg/Kg over 5 min)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Atenolol (5 mg over 5 min)
Number of subjects: 14
Study: 6978143

Group type: EXPERIMENTAL
Intervention: Heavy opiate premedication
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (no premedication)
Number of subjects: 2
Study: 31902653

Group type: COMPARATOR
Intervention: TLC + placebo
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: TLC + A/A
Number of subjects: 53
Study: 31498922

Group type: EXPERIMENTAL
Intervention: High impact exercise (EL)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control leg (CL)
Number of subjects: 42
Study: 25951117

Group type: EXPERIMENTAL
Intervention: Inter-professional training for physicians and nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (untrained unit teams)
Number of subjects: 0
Study: 27262086

Group type: EXPERIMENTAL
Intervention: Sarcosine (2g daily)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 25052710

Group type: EXPERIMENTAL
Intervention: Children with epilepsy (CWE)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Whole group (CWE and controls)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 112
Study: 22807594

Group type: EXPERIMENTAL
Intervention: Three-stage intervention including educating staff, educating patients, and auditing surgeon practices (2005-2011)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Before intervention (2001-2004)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: After intervention (2005-2011)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall caesarean section rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complicated pregnancies post-2004
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caesarean delivery rate
Number of subjects: 0
Study: 19188900

Group type: EXPERIMENTAL
Intervention: Supervised exercise program (biweekly sessions of 2 hours, energy expenditure of 2500 kJ/hour)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-specific oral advice to increase physical activity
Number of subjects: 34
Study: 17665244

Group type: EXPERIMENTAL
Intervention: High-concentration glucose intravenously during 24 hours before the operation
Number of subjects: 57
Study: 15799006

Group type: EXPERIMENTAL
Intervention: Hebervital (formulation A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Neupogen (formulation B)
Number of subjects: 24
Study: 12002769

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus granulocyte colony-stimulating factor
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Prior chemotherapy courses
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Disease status or mobilizing regimen dose
Number of subjects: 16
Study: 9578999

Group type: EXPERIMENTAL
Intervention: Preschool food service intervention program (reducing total fat to <30% of calories and saturated fat to <10% of calories)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comprehensive preschool health education curriculum focused on nutrition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood cholesterol evaluation (semiannual)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Growth and body fatness assessment
Number of subjects: 0
Study: 10201454

Group type: EXPERIMENTAL
Intervention: EUS-guided celiac block
Number of subjects: 22

Group type: COMPARATOR
Intervention: CT-guided celiac block
Number of subjects: 22
Study: 1992862

Group type: EXPERIMENTAL
Intervention: Indobufen
Number of subjects: 306

Group type: COMPARATOR
Intervention: ASA
Number of subjects: 306

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 306
Study: 6136432

Group type: EXPERIMENTAL
Intervention: morphine (10 mg)/droperidol (2.5 mg)/atropine (0.3 mg)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: pethidine (100 mg)/droperidol (2.5 mg)/atropine (0.3 mg)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: pethidine (100 mg)/droperidol (2.5 mg)
Number of subjects: 299
Study: 31727024

Group type: EXPERIMENTAL
Intervention: Nivolumab + 12-weekly ipilimumab
Number of subjects: 189

Group type: COMPARATOR
Intervention: Nivolumab + 3-weekly ipilimumab
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Nivolumab + ipilimumab
Number of subjects: 189
Study: 28935775

Group type: EXPERIMENTAL
Intervention: Sarcopenia (assessed using computed tomography scans)
Number of subjects: 237

Group type: COMPARATOR
Intervention: No sarcopenia
Number of subjects: 237
Study: 25934864

Group type: EXPERIMENTAL
Intervention: (−)‐epicatechin (100 mg/d)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: quercetin‐3‐glucoside (160 mg/d)
Number of subjects: 37

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 37
Study: 23515277

Group type: EXPERIMENTAL
Intervention: Symptom-limited Naughton protocol treadmill exercise tests in HF with reduced EF
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Symptom-limited Naughton protocol treadmill exercise tests in HF with preserved EF
Number of subjects: 13

Group type: COMPARATOR
Intervention: Activities of daily living
Number of subjects: 13
Study: 21195961

Group type: EXPERIMENTAL
Intervention: Warmed saline solution (37.5°C)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Room-temperature saline solution
Number of subjects: 64
Study: 18844082

Group type: EXPERIMENTAL
Intervention: 100 mg soy isoflavone and 440 mg Ca and 100 IU VD supplement/d (n = 26)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 440 mg Ca and 100 IU VD supplement/d (n = 26)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Observation group (T < -1.5)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Subjects with Px haplotype
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Subjects without Px haplotype
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both Ca group and Ca + soy isoflavone group
Number of subjects: 93
Study: 16580392

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH‐a) therapy for 3 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (fertile controls)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH‐a) therapy
Number of subjects: 30
Study: 15486831

Group type: EXPERIMENTAL
Intervention: Tafenoquine, 300 mg per day for 7 days (n=18)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tafenoquine, 600 mg per day for 3 days (n=19)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tafenoquine, 600 mg as a single dose (n=18)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No further treatment (n=13)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Primaquine base, 15 mg per day for 14 days (n=12)
Number of subjects: 80
Study: 11057986

Group type: EXPERIMENTAL
Intervention: Home rehabilitation
Number of subjects: 188

Group type: COMPARATOR
Intervention: Hospital rehabilitation
Number of subjects: 188
Study: 8773636

Group type: EXPERIMENTAL
Intervention: PTH 1-34
Number of subjects: 10

Group type: COMPARATOR
Intervention: Calcitriol and calcium
Number of subjects: 10
Study: 1734637

Group type: COMPARATOR
Intervention: Captopril (50 to 100 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Isosorbide dinitrate (ISDN) (10 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Captopril (50 to 100 mg) + Isosorbide dinitrate (ISDN) (10 mg)
Number of subjects: 14
Study: 6469080

Group type: EXPERIMENTAL
Intervention: Pentagastrin infusion (0.15 micrograms/kg/h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Proglumide infusion (placebo control)
Number of subjects: 10
Study: 31517700

Group type: EXPERIMENTAL
Intervention: Mixed Reality (MR) cognitive training system, 30 minutes of training 3 times a week for 6 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional computer-assisted cognitive training system, 30 minutes of training 3 times a week for 6 weeks
Number of subjects: 21
Study: 30219477

Group type: EXPERIMENTAL
Intervention: Personalized tongxie formula
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pinaverium
Number of subjects: 0
Study: 27139058

Group type: EXPERIMENTAL
Intervention: Web-based guided self-help intervention (cognitive-behavioral and problem-solving therapy supported by an online trainer; n=202)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Web-based psychoeducation program (n=204)
Number of subjects: 406
Study: 24476003

Group type: EXPERIMENTAL
Intervention: Nasogastric tube placement (Group A)
Number of subjects: 145

Group type: COMPARATOR
Intervention: No nasogastric tube placement (Group B)
Number of subjects: 145
Study: 22786596

Group type: EXPERIMENTAL
Intervention: Stress management therapy for MS (SMT‐MS)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 121
Study: 20006528

Group type: EXPERIMENTAL
Intervention: Foam sclerotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Four-layer compression bandages alone (control)
Number of subjects: 40
Study: 17323051

Group type: EXPERIMENTAL
Intervention: Severe sepsis
Number of subjects: 3877

Group type: EXPERIMENTAL
Intervention: Severe sepsis in larger hospitals
Number of subjects: 3877
Study: 15753963

Group type: EXPERIMENTAL
Intervention: Treadmill walking using NMES (n=17)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Quadriceps endurance exercise in the sitting position by NMES (n=14)
Number of subjects: 31
Study: 12169903

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (600 IU/kg before surgery)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 9445490

Group type: EXPERIMENTAL
Intervention: Allopurinol (ALLO; 40 mg/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 22
Study: 9886795

Group type: EXPERIMENTAL
Intervention: Pulse/synchronization cyclophosphamide/apheresis
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cyclophosphamide alone
Number of subjects: 18
Study: 2516122

Group type: EXPERIMENTAL
Intervention: Chicken formula
Number of subjects: 61

Group type: COMPARATOR
Intervention: LAD formula
Number of subjects: 61
Study: 981327

Group type: EXPERIMENTAL
Intervention: Amitriptyline continued for eight months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline withdrawn double-blind to placebo after two months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline withdrawn overtly to no medication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual psychotherapy from social workers
Number of subjects: 0
Study: 31980512

Group type: EXPERIMENTAL
Intervention: Self-monitoring with telemonitoring
Number of subjects: 2774

Group type: COMPARATOR
Intervention: BP self-monitoring in addition to usual care
Number of subjects: 2774
Study: 31380115

Group type: EXPERIMENTAL
Intervention: IQP-AE-103 (two dosages)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29267300

Group type: EXPERIMENTAL
Intervention: 2 min CC with 8 min rest (Group A)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: 2 min CC with 4 min rest (Group B)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: 2 min CC with 6 min rest (Group C)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: 2 min CC with 8 min rest (Group D)
Number of subjects: 143
Study: 25921965

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy with a defibrillator (CRT-D)
Number of subjects: 752

Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillator (ICD)-only therapy
Number of subjects: 752
Study: 23375640

Group type: EXPERIMENTAL
Intervention: Mind-Body Bridging (MBB; n=19)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sleep Hygiene Education (SHE; n=18)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation (MM; n=20)
Number of subjects: 57
Study: 21914906

Group type: EXPERIMENTAL
Intervention: Picture task card protocol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional protocol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Picture activity schedule protocol
Number of subjects: 22
Study: 19371931

Group type: EXPERIMENTAL
Intervention: Orchiopexy combined with neoadjuvant GnRH therapy (1.2 mg/d nasal spray for 4 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Orchiopexy alone
Number of subjects: 24
Study: 16750325

Group type: EXPERIMENTAL
Intervention: Hyperfractionated chest wall irradiation (72 Gy in 1.2-Gy b.i.d. fractions)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Once-daily chest wall irradiation (60 Gy in 2-Gy q.d. fractions)
Number of subjects: 108
Study: 15235331

Group type: EXPERIMENTAL
Intervention: CHO+P beverage (7.3% carbohydrate and 1.8% protein)
Number of subjects: 15

Group type: COMPARATOR
Intervention: CHO beverage (7.3% carbohydrate)
Number of subjects: 15
Study: 11728069

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 mg/kg body weight)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9143081

Group type: EXPERIMENTAL
Intervention: Focal transcranial magnetic stimulation with background facilitation
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Focal transcranial magnetic stimulation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 8194141

Group type: EXPERIMENTAL
Intervention: Subcutaneous morphine infusion
Number of subjects: 21

Group type: COMPARATOR
Intervention: Three-hourly subcutaneous bolus injections of morphine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Microinfusion set for subcutaneous infusion
Number of subjects: 21
Study: 2890268

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT) 25 mg daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Furosemide (Lasix Retard, LR) 30 mg daily
Number of subjects: 50
Study: 29341984

Group type: EXPERIMENTAL
Intervention: First dose of RV1 (early administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First dose of RV1 (on-time administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First dose of RV1 (late administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second dose of RV1 (early administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second dose of RV1 (on-time administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second dose of RV1 (late administration)
Number of subjects: 0
Study: 27573324

Group type: EXPERIMENTAL
Intervention: Pocket PATH mobile health application
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Moderate use of Pocket PATH (n=23)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Income meeting basic needs
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Longer hospital stays
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Past technology experience
Number of subjects: 96
Study: 26505522

Group type: EXPERIMENTAL
Intervention: Technologically delivered stigma intervention
Number of subjects: 0
Study: 22943627

Group type: EXPERIMENTAL
Intervention: Wellbeing therapy (WBT) based on personalized mobile technology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 0
Study: 20858040

Group type: EXPERIMENTAL
Intervention: SIDI‐F cutoff score of 33 in North America
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: SIDI‐F cutoff scores of 33 and 34 in Europe
Number of subjects: 428
Study: 18763690

Group type: EXPERIMENTAL
Intervention: Test toothpaste containing 0.2% zinc sulphate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo toothpaste (no zinc)
Number of subjects: 0
Study: 16284462

Group type: EXPERIMENTAL
Intervention: lamivudine (3TC) - stavudine (d4T) - IDV (800 mg three times daily)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Nevirapine (NVP) - d4T - IDV (1000 mg three times daily)
Number of subjects: 139
Study: 12028179

Group type: EXPERIMENTAL
Intervention: Home exercise program of muscle strengthening and balance retraining exercises, individually prescribed and delivered at home by trained health professionals.
Number of subjects: 1016
Study: 10513804

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (750 mg twice a day) for 12 months
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 9816009

Group type: EXPERIMENTAL
Intervention: Adoptive transfer of tumor-infiltrating lymphocytes (TIL group)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Chemotherapy only (Control group)
Number of subjects: 13
Study: 2201189

Group type: EXPERIMENTAL
Intervention: Intravaginal clindamycin
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 387329

Group type: EXPERIMENTAL
Intervention: Imipramine (75 mg at bedtime)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desmethylimipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methscopolamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31950134

Group type: COMPARATOR
Intervention: 1000 IU/d vitamin D3
Number of subjects: 225

Group type: COMPARATOR
Intervention: 2000 IU/d vitamin D3
Number of subjects: 225
Study: 25876607

Group type: EXPERIMENTAL
Intervention: Atomoxetine (placebo-controlled trials)
Number of subjects: 977

Group type: COMPARATOR
Intervention: Placebo (control group in trials)
Number of subjects: 977
Study: 28207168

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1500
Study: 25544594

Group type: EXPERIMENTAL
Intervention: Water-based exercise training
Number of subjects: 18
Study: 23920939

Group type: EXPERIMENTAL
Intervention: Relaxation technique (RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical music intervention (MMI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nature landscape applications with music (NLAM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nature landscape applications without music (NLAWM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study: 21330034

Group type: EXPERIMENTAL
Intervention: Comprehensive and intensive treatment of cardiovascular risk factors
Number of subjects: 247

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Cumulative survival rate
Number of subjects: 247